Parkinsons Disease (pd) Clinical Trials
2 recruiting trials for Parkinsons Disease (pd). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Parkinsons Disease (pd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Hospital de Clinicas de Porto Alegre (1), Vertero Therapeutics (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Dietitian-Guided Nutritional Intervention (behavioral, 1 trial).
Track Parkinsons Disease (pd) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease
The goal of this clinical trial is to evaluate whether a dietitian-guided nutritional intervention can improve constipation symptoms in people with Parkinson's disease (PD). The...
Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease
This study seeks to understand the prevalence and variability of a gut bacteria gene called csgA in people with Parkinson's Disease. This understanding could inform development of...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Parkinsons Disease (pd), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Parkinsons Disease (pd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Parkinsons Disease (pd), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.